Sort
78,016 grants matching “breast cancer”
Greater Denver Latino Cancer Prevention/Control Network
$455,848Paula A Espinoza · University Of Colorado Denver · U01 · FY2009 · CA
Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival
$455,765David Spiegel · Stanford University · R01 · FY2009 · CA
Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer
$455,764Brett Stewart Carver · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer
$455,760Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Health Literacy Intervention and Cancer Screening
$455,729Terry C Davis · Louisiana State Univ Hsc Shreveport · R01 · FY2011 · CA
BONE MARROW &SENTINEL NODE MICROMETASTASES IN BREAST CA
$455,712University Of Southern California · R01 · FY2000 · CA
Targeting Posttranslational Modifications in Breast Carcinogenesis
$455,680Yong Wan · Emory University · R01 · FY2025 · CA
Nanotechnology for targeted therapy and fundamental understanding of therapeutic resistance in triple negative breast cancer
$455,670Xiaoming He · Univ Of Maryland, College Park · R01 · FY2021 · CA
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY
$455,665Gregory M Lanza · Washington University · R01 · FY2013 · CA
Drug repurposing in breast cancer
$455,656Rong Stephanie Huang · University Of Minnesota · R01 · FY2018 · CA
Astatine And Iodine Radiolabeled Monoclonal Antibodies
$455,654Michael Rod Zalutsky · Duke University · R01 · FY2017 · CA
Astatine And Iodine Radiolabeled Monoclonal Antibodies
$455,654Michael Rod Zalutsky · Duke University · R01 · FY2016 · CA
Astatine And Iodine Radiolabeled Monoclonal Antibodies
$455,654Michael Rod Zalutsky · Duke University · R01 · FY2020 · CA
Astatine And Iodine Radiolabeled Monoclonal Antibodies
$455,654Michael Rod Zalutsky · Duke University · R01 · FY2018 · CA
Transdisciplinary Training at the Intersection of Environmental Health Science and Social Science (EH+SS)
$455,646Philip M. Brown · Northeastern University · T32 · FY2022 · ES
KANSAS CITY COMMUNITY CLINICAL ONCOLOGY PROGRAM
$455,551Kansas City Clinical Oncology Program · U10 · FY2002 · CA
Molecular Glues to Target RAS-MAPK Driven Cancers
$455,542Arvin Dar · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting macrophages in metastatic cancer
$455,525Anthony Rongvaux · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Gene Expression in Cancer by Microarray Hybridization
$455,479Patrick O. Brown · Stanford University · R01 · FY2009 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$455,443Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$455,443Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$455,443Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications
$455,433Marina Tanasova · Michigan Technological University · R15 · FY2024 · CA
An innate immune checkpoint in cancer immunotherapy
$455,406Carla Rothlin · Yale University · R01 · FY2017 · CA
Cellular hierachy of ER- breast cancers in different ethnic groups
$455,316Michael Clarke · Stanford University · U01 · FY2014 · CA